BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 30465656)

  • 1. Progressive kidney failure in chronic myelomonocytic leukaemia: don't forget lysozyme damage.
    Hillen JM; Raemaekers JM; Steenbergen EJ; Wetzels JFM; Verhave JC
    Neth J Med; 2018 Nov; 76(9):407-410. PubMed ID: 30465656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A forgotten cause of kidney injury in chronic myelomonocytic leukemia.
    Patel TV; Rennke HG; Sloan JM; DeAngelo DJ; Charytan DM
    Am J Kidney Dis; 2009 Jul; 54(1):159-64. PubMed ID: 19185401
    [No Abstract]   [Full Text] [Related]  

  • 3. Renal failure in a patient with chronic myelomonocytic leukaemia.
    Robinson GT; Sundaram KR; Dilly SA; Bevan DH; Andrews PA
    Nephrol Dial Transplant; 1997 Jul; 12(7):1500-2. PubMed ID: 9249798
    [No Abstract]   [Full Text] [Related]  

  • 4. [Lysozyme-induced nephropathy: A rare cause of renal failure in chronic myelomonocytic leukemia].
    Robinet-Zimmermann G; Rioux-Leclercq N; Frouget T; Le Naoures C
    Ann Pathol; 2020 Nov; 40(6):478-482. PubMed ID: 32444242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysozyme Nephropathy in Haematologically Stable Chronic Myelomonocytic Leukaemia.
    Goh TL; Carpenter L; Ly E
    Nephrology (Carlton); 2018 Apr; 23(4):377. PubMed ID: 29520907
    [No Abstract]   [Full Text] [Related]  

  • 6. Lysozyme-induced nephropathy: a rare manifestation of chronic myelomonocytic leukaemia.
    Maraj A; MacEneaney O; Doyle B; Quinn J
    Br J Haematol; 2020 May; 189(3):393. PubMed ID: 32026461
    [No Abstract]   [Full Text] [Related]  

  • 7. Systemic vasculitis with bilateral perirenal haemorrhage in chronic myelomonocytic leukaemia.
    Aslangul-Castier E; Papo T; Amoura Z; Baud O; Leblond V; Charlotte F; Bricaire F; Degos L; Piette JC
    Ann Rheum Dis; 2000 May; 59(5):390-3. PubMed ID: 10784523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to recombinant human erythropoietin (rHu-Epo) in a patient with chronic renal failure and myelomonocytic leukaemia.
    Salvati F; Liani M; Bonomini M
    Nephrol Dial Transplant; 2001 Jan; 16(1):191-2. PubMed ID: 11209030
    [No Abstract]   [Full Text] [Related]  

  • 9. A rare cause of acute kidney injury with chronic myelomonocytic leukemia.
    Asano M; Hase H; Naruse Y; Kawada K; Kojima I; Branch J; Kitamura H; Shimizu H
    CEN Case Rep; 2021 Aug; 10(3):320-325. PubMed ID: 33403618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous tumour lysis syndrome secondary to the transformation of chronic myelomonocytic leukaemia into acute myeloid leukaemia.
    Langridge A; Musgrave K; Upadhye Y
    BMJ Case Rep; 2016 Mar; 2016():. PubMed ID: 26961554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of human lysozyme (muramidase) on potassium handling by the perfused rat kidney. A mechanism for renal damage in human monocytic leukaemia.
    Mason DY; Howes DT; Taylor CR; Ross BD
    J Clin Pathol; 1975 Sep; 28(9):722-7. PubMed ID: 1058211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatal hyperleukocytic syndrome in a patient with chronic myelomonocytic leukemia.
    Aul C; Gattermann N; Germing U; Südhoff T; Hollmig KA; Heyll A
    Leuk Res; 1997 Mar; 21(3):249-53. PubMed ID: 9111170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal infiltration associated with chronic myelomonocytic leukaemia.
    Kobayashi K; Yokote T; Tsuji M; Takubo T; Inoue T; Hanafusa T
    Br J Haematol; 2009 Nov; 147(4):414. PubMed ID: 19538524
    [No Abstract]   [Full Text] [Related]  

  • 14. Veno-occlusive disease of the liver associated with chronic myelomonocytic leukemia treated with vincristine and standard doses of cytarabine.
    Boula AM; Mantadakis E; Xilouri IM; Christoforidou AV; Foudoulakis AM; Samonis G
    Am J Hematol; 2005 Jul; 79(3):216-9. PubMed ID: 15981233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukapheresis in chronic myelomonocytic leukemia with leukostasis syndrome: elevated serum lactate levels as an early sign of microcirculation failure.
    Stemmler J; Wittmann GW; Hacker U; Heinemann V
    Leuk Lymphoma; 2002 Jul; 43(7):1427-30. PubMed ID: 12389624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies of lysozyme activity in serum, urine and blood smears from patients with haematological diseases].
    Labedzki L; Seché G; Lorbacher P
    Klin Wochenschr; 1977 Jul; 55(14):677-83. PubMed ID: 408556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pericardial extramedullary haemopoiesis in chronic myelomonocytic leukaemia.
    Bradford CR; Smith SR; Wallis JP
    J Clin Pathol; 1993 Jul; 46(7):674-5. PubMed ID: 8157760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypokalemia of sudden onset as the 1st sign of transformation of chronic myelomonocytic leukemia].
    Cervero M; Cruz Ortiz M
    Sangre (Barc); 1990 Oct; 35(5):410-1. PubMed ID: 2291152
    [No Abstract]   [Full Text] [Related]  

  • 19. Osteolytic lesions in chronic myelomonocytic leukaemia.
    Ohri SK; Sharp DJ; Coutts GB
    Br J Clin Pract; 1990 Dec; 44(12):672-3. PubMed ID: 2102187
    [No Abstract]   [Full Text] [Related]  

  • 20. [Kaposi's sarcoma arising in a patient with chronic myelomonocytic leukaemia].
    Menezes N; Moreira A; Mota G; Tente D; Lima O; Pinto P; Gonçalves O; Baptista A
    Acta Med Port; 2010; 23(2):259-62. PubMed ID: 20470474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.